NERVGEN PHARMA CORP. - NGEN

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2026 · Compare: Q2 2022
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
PFG Investments, LLC History New 201,000 757 0.04% 1 +201,000 New Q1 2026 Apr 27, 2026
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV History New 77,698 292 0.09% 2 +77,698 New Q1 2026 Apr 21, 2026
Patriot Financial Group Insurance Agency, LLC History New 37,000 139 0.01% 3 +37,000 New Q1 2026 Apr 22, 2026
COMMONWEALTH EQUITY SERVICES, LLC History New 33,350 125 0.0% 4 +33,350 New Q1 2026 Apr 27, 2026
McKinley Carter Wealth Services, Inc. History New 30,892 116 0.01% 5 +30,892 New Q1 2026 Apr 20, 2026
Busey Bank History New 25,000 94 0.0% 6 +25,000 New Q1 2026 Apr 28, 2026
CAPTRUST FINANCIAL ADVISORS History Closed out 0 0 0.0% -30,000 -100.0% Q2 2022 Aug 23, 2022